Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osigraft vs standard treatment in distraction osteogenesis of the tibia
2005-004284-36Phase 3Terminated
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Sep 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of bone morphogenetic protein 7 in pseudoarthrosis, osteomyelitis (OM) and osteoporosis (2 arms), sponsored by Azienda Ospedaliero-Universitaria Careggi. Started Sep 2005; status: terminated.
02
Drugs
bone morphogenetic protein 7
03
Conditions
pseudoarthrosisosteomyelitis (OM)osteoporosis
Beyond the preview
Go deeper on 2005-004284-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004284-36.